Skip to main content
. 2021 Aug 2;22(4):1103. doi: 10.3892/etm.2021.10537

Table I.

Demographic characteristics at baseline of women on 2 mg drospirenone and 1 mg 17β-estradiol hormone therapy and rehabilitation (Study group) or on rehabilitation (Control group) for the Maniere's disease.

Variable Study group (n=31) Control group (n=34) P-value
Age range, years 49-56 50-56 0.9
Mean age, years (mean ± SD) 52.6±3.1 53.1±3.3 0.5
BMI, kg/m2 (mean ± SD) 26.3±4.1 25.5±5.1 0.4
Age at menopause, years (mean ± SD) 50.5±6.1 51.3±2.8 0.4
Years from menopause (mean ± SD) 5.0±3.4 6.0±4.1 0.2
Parity, n (%)      
     One 5 (16.1) 6 (17.6) 0.8
     Two or more children 26 (83.9) 28 (82.4) 0.8
Kupperman index (mean ± SD) 32.0±7.3 30.0±6.1 0.2
Cigarette smoking, n (%)      
     Non-smoker 28 (90.3) 29 (85.3) 0.9
     Current smoker 3 (9.7) 5 (14.7) 0.8
Systolic blood pressure, mmHg (mean ± SD) 132.5±11.6 134.2±15.4 0.6
Diastolic blood pressure, mmHg (mean ± SD) 83.8±8.3 82.7±7.5 0.5
Heart rate, bpm (mean ± SD) 65.8±10.3 67.4±12.2 0.5

P-values were obtained by one-way analysis of variance with Bonferroni post hoc test for non-categorical variables, and a χ2 test was used for categorical demographic variables.